학술논문

Ischemia modified albumin: A potential marker for global metabolic risk in generalized anxiety disorder and panic disorder (eng)
Document Type
article
Source
Klinik Psikiyatri Dergisi, Vol 24, Iss 2, Pp 153-159 (2021)
Subject
ischemia modified albumin
generalized anxiety disorder
panic disorder
Psychiatry
RC435-571
Therapeutics. Psychotherapy
RC475-489
Language
English
Turkish
ISSN
1302-0099
Abstract
INTRODUCTION[|]Ischemia modified albumin (IMA) is an altered type of albumin produced due to exposure to hypoxia, acidosis, inflammation, or oxidative stress. In this study, we aimed to evaluate the serum IMA levels in newly diagnosed and medication-naive generalized anxiety disorder (GAD) and panic disorder (PD) patients.[¤]METHODS[|]This cross-sectional study included medication-naive 23 GAD, 25 PD patients, and 28 healthy controls. The participants were evaluated with a sociodemographic form, the Beck Depression Inventory (BDI), and the Beck Anxiety Inventory (BAI). Venous blood samples were collected from all participants, and IMA levels and routine biochemical parameters were measured.[¤]RESULTS[|]There was no statistically significant difference between three groups in terms of age, gender, body mass index (BMI) and routine biochemical markers of the participants (p>0.05). The GAD and PD groups had significantly higher serum IMA levels than healthy controls (p